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ABSTRACT
The ardA gene, found in many prokaryotes including
important pathogenic species, allows associated
mobile genetic elements to evade the ubiquitous
Type I DNA restriction systems and thereby assist
the spread of resistance genes in bacterial popula-
tions. As such, ardA contributes to a major health-
care problem. We have solved the structure of the
ArdA protein from the conjugative transposon Tn916
and find that it has a novel extremely elongated
curved cylindrical structure with defined helical
grooves. The high density of aspartate and gluta-
mate residues on the surface follow a helical pattern
and the whole protein mimics a 42-base pair stretch
of B-form DNA making ArdA by far the largest DNA
mimic known. Each monomer of this dimeric struc-
ture comprises three alpha–beta domains, each with
a different fold. These domains have the same fold
as previously determined proteins possessing
entirely different functions. This DNA mimicry
explains how ArdA can bind and inhibit the Type I
restriction enzymes and we demonstrate that 6 dif-
ferent ardA from pathogenic bacteria can function in
Escherichia coli hosting a range of different Type I
restriction systems.
INTRODUCTION
Sequence analysis of bacterial genomes has demonstrated
that horizontal gene transfer (HGT) is a fundamental
mechanism for driving diversity and evolution. The trans-
mission of DNA to bacterial cells that are not direct
descendants of the donor is often achieved via mobile
genetic elements such as bacteriophage, plasmids and con-
jugative transposons. Mobilization of these elements can
lead to the spread of antimicrobial resistance in clinical
environments and in the wider community (1–5). Human
morbidity and mortality as a result of this trend is mir-
rored by the economic cost of, for example, the spread of
herbicide resistance genes in crop pathogens (6).
Over 50% of eubacteria and archaea contain the genes
for one or more of the four classes of known DNA restric-
tion and restriction-modiﬁcation (RM) systems (7–10).
In laboratory experiments, it is clear that the function
of these RM systems is to protect the host cell from inva-
sion by foreign DNA. RM systems work by recognizing
speciﬁc DNA sequences and triggering an endonuclease
activity which rapidly cleaves the foreign DNA allowing
facile destruction by exonucleases.
Despite the demonstrated eﬃcacy of the RM systems,
genome analysis of pathogenic bacteria from both clinical
and environment settings make it abundantly clear that
HGT by transduction, transformation and conjugation
is extremely common. The process is not only widespread
within species but also between species where RM systems
are operative. It is established that HGT is directly respon-
sible for the spread of resistance genes (11). It is therefore
important in understanding and tackling antibiotic resis-
tance to ascertain the mechanism by which HGT circum-
vents such an apparently eﬀective defence. One most likely
explanation has come from the identiﬁcation of potential
anti-RM genes within mobile genetic elements such as
phage, plasmids and transposons (12,13). These anti-RM
systems seem to have been acquired and maintained by the
host organism and their occasional activation of such
genes weakens or negates the RM defence system allowing
further HGT (14,15).
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protein, Ocr, of phage T7 (16–20) and the ArdA and
ArdB proteins very commonly found on conjugative plas-
mids and transposons in a large range of prokaryotes
(13,21–27). The Ocr protein is relatively restricted in its
distribution (28,29) but is the most fully characterized of
anti-RM proteins. Structural analysis suggests it to be a
structural mimic of DNA and it, similar to most anti-RM
systems characterized thus far, targets the Type I RM
systems (17,18,30). Other mechanisms described for evad-
ing host RM systems include loss of DNA target
sequences, modiﬁcation of the DNA, proteolysis of RM
systems and the hydrolysis of RM cofactors and have been
extensively reviewed (10,12).
Type I RM systems are a very widespread and eﬀec-
tive defence system against foreign DNA (31) perhaps
explaining their selection as targets for anti-RM systems.
Biochemically characterized Type I RM enzymes comprise
two restriction (HsdR, R) subunits, two modiﬁcation
(HsdM, M) subunits and one DNA sequence speciﬁcity
(HsdS, S) subunit in a single  440-kDa complex (32,33).
The methyltransferase (MTase) core M2S1 modiﬁes hemi-
methylated target ‘speciﬁcity’ sequences and triggers the R
subunits to act when unmethylated targets are recognized.
The restriction reaction involves extensive ATP hydrolysis
to drive DNA translocation by the helicase motifs in
each R subunit until an endonuclease activity is activated
at a site on the DNA molecule distant from the initial
speciﬁcity sequence. These RM systems can be grouped
into diﬀerent families, IA to IE so far, deﬁned by subunit
complementation in vivo, DNA hybridization, antibody
cross reactivity and, to some extent, amino acid sequence
comparison (34,35).
Despite the wide distribution of ardA genes in many
important pathogens (24), there is very little biochemical
data on their mode of action and behaviour in solution
(26,27) and no atomic structure. We now demonstrate that
ArdA from a number of pathogens is very eﬀective against
the archetypal Type I RM systems of Escherichia coli.
We also report the ﬁrst structure of an ArdA protein
and its implications for the structure of Type I RM
enzymes. ArdA forms an extremely elongated molecule
with a highly charged surface. Its structure is reminiscent
of  42bp of B-form DNA making it the largest DNA
mimic yet characterized. It has already been demonstrated
that ArdA binds to the core MTase of a Type I RM
enzyme (26,27). The ArdA structure allows a rationaliza-
tion of this behaviour.
MATERIALS AND METHODS
Escherichia coli strains
JM109 was used as a general cloning strain (Promega
Madison, WI, USA). The expression strain BL21(DE3)
was purchased from Invitrogen (Groningen,
The Netherlands). NM1261 (restriction and modiﬁcation
negative; r
–m
–), NM1049 (EcoKI RM system, Type IA),
NK354 (EcoAI RM system, Type IB), NK402 (EcoR124I
RM system, Type IC) and NM1009 (StySBLI RM system,
Type ID) were a kind gift of Professor Noreen E. Murray
(School of Biology, University of Edinburgh, UK).
The NK and NM strains were converted to DE3 lyso-
gens using the  DE3 lysogenization kit (Invitrogen) with
some modiﬁcations. Where necessary, the Selection phage
provided in the kit was replaced by NM848 (h
82 imm
21 cI,
a kind gift from Noreen Murray) which possesses the
appropriate host range. Integration of  DE3 was veriﬁed
by assessing their ability to support growth of the T7
Tester phage (supplied in the kit).
Genes for production of ArdA protein
Four ardA genes were identiﬁed in the public sequence
database held by the National Center for Biotechnology
Information (Bethesda, MD, USA) (Table 1). The gene
sequences were then synthesized by GeneArt
(Regensburg, Germany) using an optimized codon usage
pattern for expression in E. coli. To facilitate cloning, an
NdeI restriction site was engineered to overlap the ATG
start codon of each synthetic gene and a HindIII site was
also included 6bp downstream of the stop codon. The
synthesized genes were ligated into pET24a at the NdeI
and HindIII sites of the expression vector. The anticipated
sequence was subsequently veriﬁed by DNA sequencing
on both strands. Two further ardA genes from transposon
Tn916 (open reading frame 18 in Tn916) and Bacteroides
fragilis NCTC9343 (open reading frame BF1222) (25,36)
were ampliﬁed and ligated into pTrc99a (37) as previously
described (27). Amino acid substitutions were constructed
by site-directed mutagenesis using a QuikChange kit
(Stratagene, La Jolla, CA, USA) as per the manufacturer’s
instructions. Substitutions were conﬁrmed by sequencing.
Escherichia coli BL21(DE3) were transformed with the
pET24a or pTrc99a-based expression constructs and
plated onto LB agar containing 100mg/ml kanamycin or
100mg/ml carbenicillin, respectively. Single colonies were
picked and grown in LB medium supplemented with
100mg/ml of the appropriate antibiotic to an OD600 of
Table 1. The source of the ardA genes investigated
Reference Organism Gene ID Amino acid
length
Predicted
pI
Optimal protein
expression temperature,8C
25 Enterococcus faecalis Tn916 (ORF18) 165 3.91 37
36 Enterococcus faecalis V583 EF2335 166 3.91 30
37 Staphylococcus aureus Mu50 SAV0405 166 3.92 30
38 Clostridium diﬃcile 630 CD0376 167 3.78 37
39 Streptococcus agalactiae 2603V/R SAG2011 160 4.05 30
40 Bacteroides fragilis NCTC 9343 BF1222 177 3.98 37
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tion of IPTG to a ﬁnal concentration of 1mM. Growth
was continued for up to 4h before harvesting. The amount
of recombinant protein was initially assessed by SDS–
PAGE (4–15% gradient gel) analysis. In each case, a
prominent band of the anticipated molecular mass was
clearly visible in the induced cell extract, which was
absent from the control experiments conducted using the
corresponding plasmid vector without insert (data not
shown). In order to purify the recombinant proteins,
cells were grown in 10-l cultures and harvested 4h post
IPTG induction. Typically we obtained  40g wet cell
paste which was stored at –208C until required.
Assessment of in vivo activity of ArdA
The methods employed for assaying ArdA activity in vivo
used the eﬃciency of plating of phage lambda (virulent)  v
on the various strains of E. coli have been previously
described (27). All assays were performed in triplicate
and at least 50 phage plaques per plate per experiment
were counted. Experiments were performed on numerous
days with fresh samples and control experiments per-
formed each day. Little variation was observed during
the replicate experiments. The standard deviations for
the anti-restriction and anti-modiﬁcation results are
 25% or less depending on the particular ardA investi-
gated (Supplementary Table 1). The previously published
results (27) for the activity of ardA from Tn916 are
included here for completeness. Anti-restriction was
deﬁned as the eﬃciency of plating (eop) obtained with
strains containing the plasmid expressing the ardA gene
divided by the eop obtained from strains containing the
vector plasmid. The degree of anti-modiﬁcation was
assessed by determining the eop of each phage stock on
the restriction proﬁcient strain relative to the non-restrict-
ing strain. Anti-modiﬁcation was deﬁned as 1/(eop).
Structural methods
The ArdA protein from transposon Tn916 was puriﬁed as
described previously (27). Puriﬁed protein was concen-
trated to 15mg/ml in 10mM Tris, pH 7.5, 150mM
NaCl and 2mM DTT in preparation for crystallization.
Initial protein crystals were attained after screening
puriﬁed ArdA against 384 diﬀerent precipitants in 0.1ml
protein + 0.1ml precipitant hanging drops set up on the
Hamilton-Rhombix-Thermo integrated crystallization
system at 293K. Initial crystallization conditions were sto-
chastically optimized and optimum crystals were found to
grow in a precipitant range between 2.27 and 2.31mM
Na-K2-phosphate, 0.1M sodium acetate, pH 4.0 at
293K. To phase the structure a single ArdA crystal was
soaked in 50mM dipotassium tetrachloroplatinate (II) for
 2min before being back soaked in 2.4mM Na-K2-phos-
phate, 0.1M sodium acetate, pH 4.0, 25% ethylene glycol
which acted as cryoprotectant. Native and derivative data
were collected at beamline ID-29 at the ESRF, Grenoble,
France. All data were processed with XDS (38), scaled
in XSCALE and converted to scalepack format with
XPREPX. Heavy atom sites (6 Pt) were located using
SHELXD from the SHELXC/D/E (39) suite of programs
using native and derivative data with anomalous signal
(SIRAS) to 3.5A ˚ . Located sites were entered into
SOLVE/RESOLVE (40,41) and 2-fold averaging was
automatically detected. Electron density maps were pro-
duced at 3.5A ˚ and a partial model built. The Ca coordi-
nates from this model were used to automatically detect
and employ 4-fold averaging at 3A ˚ in RESOLVE after
which the asymmetric unit model was built by hand.
The structure was reﬁned using REFMAC5 (42). TLS
parameters were introduced for each domain and non-
crystallographic restraints applied throughout the reﬁne-
ment. XFIT (43) was used for manual model building. The
quality of the structure was checked with MOLPROBITY
(44). The ﬁnal reﬁned structure and data have been depos-
ited with PDB accession code 2w82. Table 2 shows the
data collection and reﬁnement details.
Phylogenetic analysis
Ninety-eight sequences of ArdA homologues were
derived from the Pfam family PF07275 (45). A distance
matrix was generated by Protdist (bootstrap analysis
used a random seed number of 3 with 100 replicates)
and analysed using Quicktree (46) before output in
PhyloWidget (47).
RESULTS
Distribution of ArdA in sequenced genomes
Genes encoding putative ArdA homologues are wide-
spread within the bacterial kingdom and can be identiﬁed
Table 2. The X-ray crystallography details (numbers in brackets refer
to the highest-resolution shell)
Data collection
Native Platinum
derivative
Wavelength
Resolution (A ˚ ) 12.5–2.8 (2.87–2.8) 17.72–3.29 (3.38–3.29)
Space group P212121 P212121
Temperature 100K 100K
Cell dimensions
a, b, c (A ˚ )
a=63.8 b=103.4
c=173.0
a=63.8 b=104.5
c=171.5
Vm(A ˚ 3/Da) 3.73 3.74
Solvent (4mol/asu%) 67 67
Total number
reﬂections
68208 140499
Unique reﬂections 27101 33192
I/sI 12.6 (1.8) 9.31 (2.31)
Redundancy 2.5 (2.5) 4.2 (4.1)
Completeness (%) 93.3 (93.6) 99.2 (95.4)
Anomalous
correlation (%)
40
Rmerge 6.4 (56.5) 10.6 (65.3)
Reﬁnement
Rwork/Rfree 20.7 (30.9)/24.9 (33.8)
No. atoms
Protein 10203
Water 51
R.m.s deviations
Bond lengths (A ˚ ) 0.006
Bond angles (8) 0.817
Nucleic Acids Research, 2009,Vol.37, No. 15 4889by sequence homology in the Actinobacteria, the
Cyanobacteria, the Proteobacteria and the Firmicutes
(data not shown). This is consistent with the known pro-
miscuity of conjugative plasmids and conjugative transpo-
sons such as Tn916. Interestingly the genus Bacillus does
not, as yet, appear to contain any identiﬁable homologues
of ArdA.
ArdA activity in vivo
Previously, in vivo assays have been performed for a few
ArdA proteins from conjugative plasmids speciﬁc for
E. coli against the IA, B and C families of Type I RM
systems (13,21–24,26,48,49). Similar anti-restriction and
anti-modiﬁcation activities of the Ocr protein have been
determined against the IA to ID families (34,35). Ocr was
found to act as an anti-restriction protein against all four
families but was only eﬀective as an anti-modiﬁcation pro-
tein against the IA and ID families (16,19,30).
We have tested the in vivo activity of ArdA proteins
from six bacterial species (25,50–53,36) (Table 1) against
representatives of the four major Type I RM families
(Table 3, Supplementary Table 1). We arbitrarily deﬁne
that the anti-restriction and anti-modiﬁcation activities
should have a value >2 for the ArdA protein to be con-
sidered truly active in vivo. The eﬀectiveness varies greatly
between diﬀerent ArdA proteins and between diﬀerent
Type I RM families. All of the ArdA proteins were
active as both anti-restriction and anti-modiﬁcation pro-
teins against the IA family, the IB family and the ID
family. ArdA showed anti-restriction activity against the
IC family, although the anti-modiﬁcation activity of the
ArdA from S. agalactiae and from B. fragilis was unmea-
surable against the IC family. Despite these variations, the
fact that all the ArdA were active in blocking restriction to
a measurable extent in an unnatural host without induc-
tion of high levels of protein expression suggests that these
ArdA will function eﬃciently as anti-restriction proteins if
expressed in their normal hosts and be capable of modu-
lating HGT.
ArdA crystal structure
The monomer structure. The asymmetric unit contains
four monomers of the protein forming two independent
dimers. Each monomer can be decomposed into three
domains: the N-terminal domain 1 (residues 3–61), the
central domain 2 (62–103) and the C-terminal domain
3 (residues 104–165) (Figure 1). The three domains of
the ArdA monomer are arranged in an approximately
linear manner giving a very elongated molecular shape
(70A ˚  20A ˚ ) with a deﬁnite curve. The arrangement of
the three domains has no counterpart in any known struc-
ture. As a consequence of the elongated arrangement, only
eight residues are buried from solvent. In eﬀect the protein
lacks the conventional hydrophobic core. Superimposing
the four monomers in the asymmetric unit reveals very
small variations in the precise arrangement of the domains
with respect to each other despite the limited contact area
between the domains.
The N-terminal domain consists of a three-stranded
anti-parallel b sheet and one short a helix interspersed
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4890 Nucleic Acids Research, 2009, Vol. 37,No. 15with three large loops of 10 or more residues. The arrange-
ment of the secondary structure elements is reminiscent of,
but distinct from, the B domain in biotin carboxylase (54)
(PDB 1w96), residues 248–293, from yeast (rmsd 2.1A ˚
over 36 residues). The central domain of ArdA is a four-
helix bundle and shows weak similarity to the anti-
termination ANTAR domain found in RNA-binding
proteins (55). A superposition of the central domain
with the closest structural match (PDB 1sd5) has rmsd
of 3.2A ˚ for 40 Ca atoms. The N-terminal and central
domain pack against each other burying around 1700 A ˚ 2
of surface area. The junction of the two domains creates a
cleft with approximate dimensions 15 10A ˚ , which is par-
tially occluded by the 12-residue loop connecting the two
domains. The C-terminal domain has a three-stranded
b sheet and three a helices packed together in a manner
that creates a groove in the structure  11A ˚ wide. The
C-terminal residue of the protein (Y165) is at the very
end of the middle b strand. The helical arrangement
in the C-terminal domain contains a component of the
winged helix–turn–helix motif. Superposition of the
C-terminal domain with arginine repressor protein (56)
(PDB code 2p5l) reveals 42 Ca atoms superimpose with
an rmsd of 2.1A ˚ . The arrangement of domains 2 and 3
occludes only 600 A ˚ 2 and no cleft is observed at the junc-
ture of domains 2 and 3.
Although domains 2 and 3 from ArdA have folds rem-
iniscent of nucleotide binding proteins, a comparison of
the electrostatic surface of ArdA shows these domains
have a profoundly negative potential (the pI of ArdA
is 4), the opposite of the profoundly positive potential
on nucleotide binding proteins. This reversal in surface
potential would seem to rule out ArdA as a DNA-
(or RNA)-binding protein. It remains an open question
whether the similarity is due to evolutionary divergence
or simply that the robust structural frameworks of
DNA-binding proteins and ArdA have been arrived at
by convergent evolution.
The dimer structure and its mimicry of DNA. Analysis
of the structure with the program PISA (57) identiﬁes a
head-to-head dimeric arrangement as the functional bio-
logical unit (Figure 2a and b). The presence of two such
independent dimers in the asymmetric unit is additional
evidence for the biological signiﬁcance of the arrange-
ment. A small a-helix in one monomer (residues L11
to E16) is replaced with a short loop in the other
subunit. The dimer, like the monomer, is highly elongated
and curved. The chord that connects the extreme ends
has a length of 140A ˚ . There is no evidence in the crystal
structure for higher order oligomers such as those
observed for a DNA mimic encoded by a eukaryotic
virus (58). This would appear to be inconsistent with our
previous gel ﬁltration analysis in which the molecular
weight of the protein increased on going from low con-
centration ( 0.1mM) to high concentration ( 10mM)
(27). The chromatography calibration relied upon glob-
ular protein standards. As the structure of ArdA is now
revealed to be highly elongated such a calibration is
not valid and the gel ﬁltration data, originally interpreted
as a change from a dimer at low concentration to possi-
bly a hexamer at high concentration, should now per-
haps be interpreted as a change from monomer to
dimer. This would be consistent with the observation
Figure 1. Domains in the Tn916 Orf18 ArdA monomer. (a) The N-terminal domain 1 is red, the central domain 2 is orange and the C-terminal
domain is blue. (b) An electrostatic representation of each ArdA domain demonstrating their negatively charged surface. The panel on the extreme
right has DNA from the structure 2p5l (DNA bound to the winged helix–turn–helix domain) modelled on to the ArdA domain 3. As can be seen, the
charges on ArdA are not consistent with binding of DNA despite its fold being similar to that of 2p51. (c) Electrostatic representations of domains
homologous to ArdA, including the DNA binding motif of 2p5l. Although the overall folds of the biotin carboxylase B domain (1w96), the ANTAR
domain (1sd5) and the winged helix–turn–helix domain (2p51) are similar to those in ArdA, the charge distributions are very diﬀerent.
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concentration followed a simple one step binding equilib-
rium equation. The high protein concentration used
for crystallization is near the upper limit of the concen-
tration range studied by the gel ﬁltration experiment and
the crystallization sample eluted as a single peak as
expected (27).
The two ArdA dimers in the unit cell when compared to
each other show minor variation along the molecular axis
consistent with a ﬂexible dimer interface. The highly elon-
gated dimer has a very large solvent surface area of 20000
A ˚ 2. Examining the protein surface with a 1.5-A ˚ probe
shows a wide and narrow groove running the length of
the structure, akin to the major groove in DNA. In addi-
tion to the general negative potential of the surface, there
are two ribbons of negative charge on a raised surface that
entwine around the entire length of the molecule
(Figure 2c). This striking pattern is reminiscent of the
phosphate backbone of a polynucleotide. Many of the
carboxyl groups can be superimposed upon the DNA
(32) structure derived from the structural model of a
Type I MTase core bound to DNA (Figure 2d). The pat-
tern of negative charge even extends across the dimer
interface through the conserved residues D109, D111,
D112, D115, E122, E123 and E129. This distribution
and conservation of charged residues is evidence for
the necessity of dimer formation for protein function
and suggests that ArdA across all species will have similar
structural requirements.
The residues, F91, Y137, I138 and F161 were previously
identiﬁed as essential (26). The crystallographic data
suggest their role is not functional per se but rather they
maintain the fold of the protein at the dimer interface
(Y137 and I138) and at the interface of domains 2 and 3
(F91 and F161) (Figure 2a and b).
The essential VF-motif (I160 F161 in the Tn916 ArdA
protein) is located in the domain 3 of ArdA (26) and is
part of the middle b-strand in this domain. Removal of
these residues (26) would cause the b-sheet to collapse
destroying the structural integrity of domain 3 and the
interface with domain 2. F161 and I163, on the interface
between domains 2 and 3, contact E79, L80, E83 and F91
(another essential residue) in domain 2.
The dimer interface (Figure 3) contains the anti-restric-
tion motif (amino acids 126–140 in the Tn916 ArdA pro-
tein) identiﬁed by Belogurov and Delver (59) and the two
essential residues Y137 and I138 identiﬁed by molecular
genetics (26). The structure makes it clear that this motif
serves a structural purpose rather than being involved
directly in the anti-restriction activity. The dimer buries
just under 600 A ˚ 2 per monomer (<6% of the total surface
area) but is predominantly hydrophobic with L127, L134
and Y137 providing the bulk of the contacts. There are
four hydrogen bonds; two involving main chain to main
chain contacts (Y137 to D139) and two side chain to side
chain contacts (Y137 to D146). Y137 and I138 are at the
core of the dimer interface with Y137 making two H-bond
contacts with D139 and D146 of the opposing monomer
and I138 acting to stabilize the loop regions either side of
the interface helix through interaction with V130 on the
same monomer.
The structure of ArdA compared to other ArdA
sequences
Figure 4 shows an alignment of the amino acid sequences
of the ArdA investigated in this study and by others
(13,21–27). As can be seen, there is considerable variability
in sequence in this set but the pattern of charged residues
and the two motifs identiﬁed previously (26,59) are well
conserved, indicating that all ArdA are very likely to have
the same structure and to operate in the same manner.
Biochemical data on the ArdA listed in Table 1
(Roberts,G.A. and Sanghvi,B., unpublished data) when
compared to that from Tn916 ArdA (27), support this
assertion.
Figure 2. The dimeric structure of ArdA and its distribution of negative
charge clearly show mimicry of the DNA double helix. (a) The ArdA
dimer with domain 1 coloured red and salmon, domain 2 coloured
orange and yellow and domain 3 coloured blue and cyan. Residues
F91, Y137, I138 and F161 are shown space-ﬁlled. F91 is orange,
Y137 and I138 are blue and located at the dimer interface and F161
is blue and at the interface with domain 2. (b) The ArdA dimer rotated
908 from (a) looking at the convex face. The residues F91, Y137, I138
and F161 are highlighted as above. (c) The surface of ArdA in the
same orientation as in (b) with acidic residues coloured red and basic
residues coloured light blue. The negatively charged residues form a
helical pattern across the surface. (d) An overlay of a selection of the
acidic residues in the dimer, viewed from the same angle as in (b) and
(c), onto the DNA duplex from the model structure of the MTase
bound to DNA (32). Only the phosphate backbone of DNA is
shown (red and white but with the nucleotides ﬂipped out by the
MTase for methylation shown in blue) with acidic residues from
ArdA matching one strand shown in yellow and matching the other
strand shown in green.
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The interaction of ArdA with the EcoKI Type I RM
enzyme: comparison of ArdA with the DNA
footprint of the enzyme
The ArdA dimer appears to mimic  42bp of bent B-form
DNA. This is comparable in length to the footprint of the
EcoKI Type IA RM enzyme, without its cofactors, on
DNA (60,61). In comparison, the Ocr dimer from phage
T7 mimics only  24bp, similar in length to the  30-bp
footprint of the Type I RM enzyme in the presence of its
cofactors and to the footprint of the MTase core,
M.EcoKI, of the Type I RM enzyme (60–62). Binding
experiments for the interaction of Ocr with M.EcoKI indi-
cated that Ocr was engulfed by the MTase core (63) and
this has recently been conﬁrmed by image reconstruction
from electron micrographs of an M.EcoKI–Ocr complex
(32). The typical DNA target for a Type I RM enzyme
is  14-bp long and bipartite, e.g. EcoKI recognizes
50-AACNNNNNNGTGC-30, and lies centrally in the
experimental DNA footprints. Figure 5a shows the
M.EcoKI–DNA model built using the EM reconstruction
(32) with the DNA extended in length to 42bp. Figure 5b
shows the ArdA structure within the M.EcoKI structure.
This is derived by taking advantage of the superposition
of carboxylates in ArdA and phosphates in DNA
(Figure 2d). A correspondence between the domains of
ArdA and the regions of DNA is obvious: domain 3 over-
laps the EcoKI target sequence, domain 2 contacts the
extremities of the DNA-binding groove in M.EcoKI
and domain 1 projects beyond the M.EcoKI structure.
The footprint of the entire EcoKI RM enzyme is  42bp
(61), hence it would appear that domain 1 mimics the
region of DNA in contact with the HsdR restriction sub-
units of EcoKI (these HsdR subunits are of course absent
from the MTase structure). This would also be consistent
with the model proposed recently from the structure of
HsdR (33). This model approximately placed the HsdR
against the ends of the DNA-binding groove in the
MTase. Their placement would be consistent with the
ArdA-MTase model in Figure 5b and earlier footprinting
data. However, the exact orientation of the two HsdR
with respect to the MTase is still unknown and large
changes in the DNA footprint of the EcoKI nuclease
(61) suggest large conformational changes. In addition,
the 12-residue loop linking domains 1 and 2 may indicate
that domain 1 can move relative to the rest of the protein
to better contact the HsdR subunits. Domain 1 is not
essential for anti-restriction as it can be deleted (26) indi-
cating that the key aspect of anti-restriction by ArdA is
the binding to the MTase core using domains 2 and 3.
The degree of anti-restriction observed in vivo varied
considerably between diﬀerent ArdA and diﬀerent Type
I families (from 7 to 70000). The Type I RM systems are
all expressed from a single chromosomal copy of their
genes but because of the diﬀerent stabilities of the Type
I enzymes (63–65), the number of active enzyme molecules
in the diﬀerent host strains may vary considerably. The
number of EcoKI Type I enzyme has been estimated as
<100 per cell (66,67). The number of target sequences on
phage lambda for the RM enzymes also varies with 5, 1,
14 and 3 targets for the IA, IB, IC and ID systems, respec-
tively. In addition, the expression levels of the diﬀerent
ardA genes may vary. These factors may account for the
unpredictable diﬀerences in anti-restriction. The IA, ID
and, taking into account the single target site, IB systems
Figure 3. The ArdA dimer interface showing the residues involved in H-bonding (m/c indicates a main chain H-bond).
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into account the number of potential target sequences for
the IC system, the IC system seems rather resistant to
ArdA. This is perhaps because even a single interaction
of the IC enzyme with one of the numerous target
sequences on the phage DNA would lead to restriction
and there is insuﬃcient ArdA to knock out every
enzyme molecule. However, it is also noticeable that the
IC enzyme is most able to carry out its methylation func-
tion as shown by a low anti-modiﬁcation value for most of
the ArdA (anti-modiﬁcation varies between 1 and 10000).
This diﬀerence in the ability of ArdA to inhibit methyla-
tion of phage DNA by Type I families may reﬂect diﬀerent
binding aﬃnities of the ArdA proteins for the Type I
enzymes. At present, binding aﬃnity is not well character-
ized but for the ArdA–EcoKI interaction it has been esti-
mated that the dissociation constant, Kd,i s<1nMin vitro
(27) and  170nM in vivo (68). This is not as strong as the
interaction between Ocr and EcoKI, where the Kd is
 50pM (69); therefore, perhaps ArdA is just not such a
strong competitive inhibitor as Ocr. A weaker equilibrium
binding aﬃnity would allow a greater fraction of the RM
enzymes to remain active in vivo. These questions will only
be addressable with extensive in vitro analysis of diﬀerent
ArdA/RM enzyme combinations.
The ArdA structure and that of other DNA mimics, e.g.
the phage lambda gam protein which inhibits the RecBCD
exonuclease (70), has implications for HGT. The ArdA
structure is a novel fold comprising three small domains,
each of a known fold, arranged in a row in each monomer.
The dimer interface is very small and the overall protein
is extremely elongated and decorated with negative side
chains arranged to mimic the phosphate backbone
of DNA. The evolution of ArdA is curious as two of its
domains show a related fold but the opposite charge to
oligonucleotide binding proteins. The sequential acquisi-
tion of single-point mutations to code for a predominance
of acidic amino acids and DNA mimicry is certain to be a
rare event. This may be the reason that few mimics of
extended DNA structures have been found. This rarity
may also mean that whenever the mimics do arise, they
spread rapidly throughout their ecological niche, for
Figure 4. CLUSTALW multiple sequence alignment of ArdA proteins in Table 1 plus ArdA from several previously studied conjugative plasmids
from diﬀerent incompatibility groups. The colours above each residue in the sequence alignment indicate the domain of the Tn916 Orf18 ArdA; red
is domain 1, orange is domain 2 and blue is domain 3. Secondary structure from the crystallographic analysis is shown above the sequence as
cylinders for helix and block arrows for strands. The secondary structure assignment is from the ﬁrst monomer of the dimer. The second monomer
lacks the ﬁrst helix. Acidic residues that entwine ArdA are highlighted in red and magenta. Those conserved across the dimer interface
are highlighted with asterisk. Highlighted in an open box are the ‘anti-restriction motif’ (59) and the VF-motif both essential for activity (26).
The region of ArdA from the conjugative plasmid pColIb-P9 that can be deleted without loss of anti-restriction activity is highlighted in grey (26).
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plasmids and transposons (24,26,27,59), phage T7 Ocr is
found in other related phage (28,29) and the MfpA pen-
tapeptide repeat protein (71) involved in quinolone resis-
tance is spreading rapidly (4). Recently, a DNA mimic has
been found in a highly infectious eukaryotic virus of crus-
taceans (58). One may anticipate that this mimic will also
spread rapidly.
All ArdA tested here are active against restriction
by Type I RM systems, so if they are expressed in their
natural host then they will certainly function as anti-
restriction proteins to assist HGT allowing, for example,
the acquisition of resistance genes. HGT would be ram-
pant without the existence of RM systems resulting in
disruption of the host genome. An interplay between
anti-restriction systems and RM systems is clearly beneﬁ-
cial for the evolution of bacterial species.
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